Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma

OBJECTIVES: CD133 is considered a cancer stem cell (CSC) marker in various malignancies; however, its role as a biomarker of malignant melanoma remains controversial. The present study was conducted to evaluate the suitability of CD133 surface antigen as a CSC marker in melanoma. METHODS: Human mela...

Descripción completa

Detalles Bibliográficos
Autores principales: Korn, Philippe, Kampmann, Andreas, Spalthoff, Simon, Jehn, Philipp, Tavassol, Frank, Lentge, Fritjof, Gellrich, Nils-Claudius, Zimmerer, Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408398/
https://www.ncbi.nlm.nih.gov/pubmed/34048190
http://dx.doi.org/10.31557/APJCP.2021.22.5.1591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408398/
https://www.ncbi.nlm.nih.gov/pubmed/34048190
http://dx.doi.org/10.31557/APJCP.2021.22.5.1591

Ejemplares similares